Qube Research & Technologies (QRT)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.99M Buy
51,000
+3,600
+8% +$290K ﹤0.01% 1751
2026
Q1
$4.11M Sell
47,400
-45,700
-49% -$4.38M ﹤0.01% 1768
2025
Q4
$8.94M Buy
93,100
+68,700
+282% +$6.67M 0.01% 1420
2025
Q3
$2.32M Sell
24,400
-179,600
-88% -$16.5M ﹤0.01% 2168
2025
Q2
$17.8M Buy
204,000
+126,500
+163% +$10.7M 0.02% 952
2025
Q1
$6.96M Buy
77,500
+77,400
+77,400% +$6.93M 0.01% 1354
2024
Q4
$7.99K Buy
+100
New +$8.66K ﹤0.01% 3254
2024
Q2
Sell
-7,100
Closed -$619K 4378
2024
Q1
$619K Buy
7,100
+7,000
+7,000% +$597K ﹤0.01% 2419
2023
Q4
$8.24K Buy
+100
New +$7.62K ﹤0.01% 3637

Other funds holding MDT

Qube Research & Technologies (QRT)'s MDT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Medtronic (MDT) stake by 3,522% in Q2 2026, buying an estimated $217M and bringing the position to 2,770,165 shares worth $217M. The position accounts for 0.2% of the portfolio, ranked #115.

Qube Research & Technologies (QRT) first reported a position in MDT in Q1 2018 and has held it in 30 quarters since. The position peaked at $274M in Q4 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Qube Research & Technologies (QRT) held 2,770,165 shares of Medtronic worth $217M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 2,693,680 Medtronic shares in Q2 2026, an estimated $217M.
  • Medtronic made up 0.2% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #115 holding.
  • Qube Research & Technologies (QRT) first reported a position in Medtronic in Q1 2018 and has held it in 30 quarters since.
  • Qube Research & Technologies (QRT)'s Medtronic position peaked at $274M in Q4 2024.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.